{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:57:49Z","timestamp":1779400669586,"version":"3.53.1"},"reference-count":52,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Sciences"],"abstract":"<jats:p>In vitro models have revolutionized our understanding of biological pathways and mechanisms, offering a viable alternative to direct patient testing. However, there is a significant lack of models for different animals, particularly equine models. This study presents a novel primary cell culture extracted from a 3-year-old horse diagnosed with multisystemic eosinophilic epitheliotropic disease. Tissue samples were collected from lymph nodes at various locations. Growth curves of extracted primary cells were analyzed and the optimal conditions were assessed. Biomarkers, such as CD31, ZO-1, CD79, Beta-catenin, E-cadherin, and LYE-1, were detected using an immunofluorescence assay, indicating that these primary cells are of endothelial origin. Initial whole-genome sequencing was performed to confirm the species\u2019 origin and to identify the number of common variations in comparison with the NIH EquCab3.0 reference genome. For the first time, the establishment of primary equine cells from lymph nodes is reported, and these can be used as an in vitro model for testing drug responses, molecular pathways, and environmental effects.<\/jats:p>","DOI":"10.3390\/vetsci12090905","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T12:54:26Z","timestamp":1758200066000},"page":"905","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Isolation and Characterization of Equine Lymph Node Endothelial Cells"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3302-2927","authenticated-orcid":false,"given":"Tomas","family":"Lugo","sequence":"first","affiliation":[{"name":"School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9625-4886","authenticated-orcid":false,"given":"Stephanie","family":"Myers","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9952-3869","authenticated-orcid":false,"given":"Thu Annelise","family":"Nguyen","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/01926230600867727","article-title":"Normal Structure, Function, and Histology of Lymph Nodes","volume":"34","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"jcs241828","DOI":"10.1242\/jcs.241828","article-title":"The lymph node at a glance\u2013how spatial organization optimizes the immune response","volume":"133","author":"Grant","year":"2020","journal-title":"J. Cell Sci."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ozulumba, T., Montalbine, A.N., Ortiz-C\u00e1rdenas, J.E., and Pompano, R.R. (2023). New tools for immunologists: Models of lymph node function from cells to tissues. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1183286"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Morgan, E.A. (2014). Surgical Pathology of Hematopoietic Neoplasms. Pathobiol. Hum. Dis. A Dyn. Encycl. Dis. Mech., 3607\u20133627.","DOI":"10.1016\/B978-0-12-386456-7.06908-2"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semcdb.2015.01.008","article-title":"The lymph node microenvironment and its role in the progression of metastatic cancer","volume":"38","author":"Pereira","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1089\/lrb.2013.0012","article-title":"Lymphatic function and immune regulation in health and disease","volume":"11","author":"Liao","year":"2013","journal-title":"Lymphat. Res. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev-bioeng-082420-124920","article-title":"Modeling Immunity in Vitro: Slices, Chips, and Engineered Tissues","volume":"23","author":"Hammel","year":"2021","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_9","first-page":"1083","article-title":"A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies","volume":"88","author":"Ramaiahgari","year":"2014","journal-title":"Arch. Toxicol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tibtech.2020.07.009","article-title":"In Vitro Models of Intestine Innate Immunity","volume":"39","author":"Roh","year":"2021","journal-title":"Trends Biotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e13695","DOI":"10.1111\/cts.13695","article-title":"Complex in vitro model: A transformative model in drug development and precision medicine","volume":"17","author":"Wang","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Richter, M., Piwocka, O., Musielak, M., Piotrowski, I., Suchorska, W.M., and Trzeciak, T. (2021). From Donor to the Lab: A Fascinating Journey of Primary Cell Lines. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.711381"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/CH-141877","article-title":"Isolation of equine endothelial cells and life cell angiogenesis assay","volume":"58","author":"Dietze","year":"2014","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.vetmic.2008.10.010","article-title":"Characterization of an equine macrophage cell line: Application to studies of EIAV infection","volume":"136","author":"Craigo","year":"2009","journal-title":"Vet. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lessiak, U., Pratscher, B., Tichy, A., and Nell, B. (2023). Bevacizumab Efficiently Inhibits VEGF-Associated Cellular Processes in Equine Umbilical Vein Endothelial Cells: An In Vitro Characterization. Vet. Sci., 10.","DOI":"10.3390\/vetsci10110632"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.5966\/sctm.2014-0138","article-title":"Peripheral Blood-Derived Mesenchymal Stromal Cells Promote Angiogenesis via Paracrine Stimulation of Vascular Endothelial Growth Factor Secretion in the Equine Model","volume":"3","author":"Bussche","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00480169.2012.753569","article-title":"Equine multisystemic eosinophilic epitheliotropic disease: A case report and review of literature Equine multisystemic eosinophilic epitheliotropic disease: A case report and review of literature","volume":"61","author":"Bosseler","year":"2013","journal-title":"N. Z. Vet. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1939-1676.2000.tb01164.x","article-title":"Chronic Idiopathic Inflammatory Bowel Diseases of the Horse","volume":"14","author":"Schumacher","year":"2000","journal-title":"J. Vet. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/eve.12017","article-title":"Pulmonary and hepatic eosinophilic granulomas and epistaxis in a horse suggestive of multi-systemic eosinophilic epitheliotropic disease","volume":"25","author":"Horan","year":"2013","journal-title":"Equine Vet. Educ."},{"key":"ref_20","first-page":"1190","article-title":"Case Report Rapport de cas Inflammatory bowel disease characterized by multisystemic eosinophilic epitheliotropic disease (MEED) in a horse in Saskatchewan, Canada","volume":"62","author":"Vogt","year":"2021","journal-title":"Can. Vet. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jcpa.2023.01.005","article-title":"Multisystemic eosinophilic epitheliotropic disease in three donkeys","volume":"201","author":"Paraschou","year":"2023","journal-title":"J. Comp. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/030098589803500209","article-title":"Multisystemic, eosinophilic, epitheliotropic disease with intestinal lymphosarcoma in a horse","volume":"35","author":"Piercy","year":"1998","journal-title":"Vet. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10565-006-0175-0","article-title":"In vitro models of intestinal epithelial cell differentiation","volume":"23","author":"Turck","year":"2007","journal-title":"Cell Biol. Toxicol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1021\/acsbiomaterials.7b00368","article-title":"In Vitro Generation of Mouse Colon Crypts","volume":"3","author":"Wang","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Rooney, M.F., Neto, N.G.B., Monaghan, M.G., Hill, E.W., and Porter, R.K. (2023). Conditionally immortalised equine skeletal muscle cell lines for in vitro analysis. Biochem. Biophys. Rep., 33.","DOI":"10.1016\/j.bbrep.2022.101391"},{"key":"ref_26","unstructured":"National Research Council (1999). Summary of Advantages and Disadvantages of In Vitro and In Vivo Methods. Monoclonal Antibody Production, National Academies Press."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s12015-023-10507-3","article-title":"In Vitro Generated Equine Hepatic-Like Progenitor Cells as a Novel Potent Cell Pool for Equine Metabolic Syndrome (EMS) Treatment","volume":"19","author":"Marycz","year":"2023","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.virol.2007.11.037","article-title":"Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: Model systems for equine sarcoids","volume":"373","author":"Yuan","year":"2008","journal-title":"Virology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Evans, E., Paillot, R., and L\u00f3pez-\u00c1lvarez, M.R. (2018). A comprehensive analysis of e-CAS cell line reveals they are mouse macrophages. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-26512-3"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1038\/s41467-019-11415-2","article-title":"Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types","volume":"10","author":"Yu","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/spmg.19885","article-title":"Cell lines: Valuable tools or useless artifacts","volume":"2","author":"Kaur","year":"2012","journal-title":"Spermatogenesis"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/MOH.0000000000000239","article-title":"Endothelial functions of PECAM-1 (CD31)","volume":"23","author":"Lertkiatmongkol","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/micc.12111","article-title":"Vimentin as an integral regulator of cell adhesion and endothelial sprouting","volume":"21","author":"Dave","year":"2014","journal-title":"Microcirculation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1083\/jcb.201404140","article-title":"ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation","volume":"208","author":"Tornavaca","year":"2015","journal-title":"J. Cell Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","article-title":"The cell-cell adhesion molecule E-cadherin","volume":"65","author":"Berx","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"33671","DOI":"10.1074\/jbc.M702889200","article-title":"Inflammation-induced Uptake and Degradation of the Lymphatic Endothelial Hyaluronan Receptor LYVE-1","volume":"282","author":"Johnson","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/dvdy.21605","article-title":"Expression of the hyaluronan receptor LYVE-1 is not restricted to the lymphatic vasculature; LYVE-1 is also expressed on embryonic blood vessels","volume":"237","author":"Gordon","year":"2008","journal-title":"Dev. Dyn."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1083\/jcb.144.4.789","article-title":"LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan","volume":"144","author":"Banerji","year":"1999","journal-title":"J. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.matbio.2018.02.001","article-title":"Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking","volume":"78\u201379","author":"Jackson","year":"2019","journal-title":"Matrix Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1600-0463.2004.apm11207-0811.x","article-title":"Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis","volume":"112","author":"Jackson","year":"2004","journal-title":"APMIS"},{"key":"ref_41","first-page":"1271","article-title":"The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues","volume":"16","author":"Wilting","year":"2002","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jdsr.2010.01.003","article-title":"New trends in the study of podoplanin as a cell morphological regulator","volume":"46","author":"Sawa","year":"2010","journal-title":"Jpn. Dent. Sci. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Quintanilla, M., Montero, L.M., Renart, J., and Villar, E.M. (2019). Podoplanin in inflammation and cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030707"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Astarita, J.L., Acton, S.E., and Turley, S.J. (2012). Podoplanin: Emerging functions in development, the immune system, and cancer. Front. Immunol., 3.","DOI":"10.3389\/fimmu.2012.00283"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood-2010-12-326447","article-title":"Tissue inflammation modulates gene expression of lymphatic endothelial cells and dendritic cell migration in a stimulus-dependent manner","volume":"118","author":"Vigl","year":"2011","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00129039-200106000-00001","article-title":"CD79: A review","volume":"9","author":"Chu","year":"2001","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B Cell Responses: Cell Interaction Dynamics and Decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ager, A. (2017). High endothelial venules and other blood vessels: Critical regulators of lymphoid organ development and function. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00045"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.it.2022.07.002","article-title":"High endothelial venules as potential gateways for therapeutics","volume":"43","author":"Hussain","year":"2022","journal-title":"Trends Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Vella, G., Guelfi, S., and Bergers, G. (2021). High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.736670"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10456-021-09792-8","article-title":"High endothelial venules (HEVs) in immunity, inflammation and cancer","volume":"24","author":"Blanchard","year":"2021","journal-title":"Angiogenesis"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zhu, W., Zheng, D., Wang, D., Yang, L., Zhao, C., and Huang, X. (2021). Emerging Roles of Ubiquitin-Specific Protease 25 in Diseases. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.698751"}],"container-title":["Veterinary Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-7381\/12\/9\/905\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:47:47Z","timestamp":1760035667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-7381\/12\/9\/905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":52,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["vetsci12090905"],"URL":"https:\/\/doi.org\/10.3390\/vetsci12090905","relation":{},"ISSN":["2306-7381"],"issn-type":[{"value":"2306-7381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]}}}